These are led by the EMA executive steering group on shortages and safety of medicinal products ... industry stakeholders. The end goal is to ensure medicine availability for EU patients during ...

This arrangement means that medicinal products on the market in NI must be authorised in line with the EU regime, which no longer applies in Great Britain. This causes difficulties for companies ...

The general objective of the proposed regulation, which complements the ongoing revision of the EU pharmaceutical legislation, is to strengthen the security of supply and the availability of critical ...

On 16 April 2025, the European Commission (EC) published a press release announcing the launch of and details regarding the first two medicinal products to undergo joint clinical assessments (JCAs).

The EU opens consultations and publishes list ... countermeasures in the form of export restrictions on selected products. Stakeholders are invited to submit comments by June 10.

Basel, 30 April 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Medicines Agency’s Committee for Medicinal Products for Human Use ... care for each person we partner with ...